Can I Take Hydrocodone With Cyclobenzaprine?

Taking hydrocodone and cyclobenzaprine together is technically possible and does happen under medical supervision, but the combination carries meaningful risks that both patients and prescribers need to take seriously. Both drugs depress the central nervous system, and guidelines specifically caution against the pairing because of additive sedation and the potential for slowed breathing.¹ A less well-known risk, serotonin syndrome, has also been reported with this specific drug pair. Whether the combination is acceptable for you depends on dosing, duration, your other medications, and individual risk factors that only your prescriber can weigh.

Why These Two Drugs Together Increase Sedation Risk

Hydrocodone is an opioid painkiller. Cyclobenzaprine is a muscle relaxant most people know by its former brand name, Flexeril. Both of them slow down activity in the brain and spinal cord, which is exactly how they each do their jobs: hydrocodone dulls pain signals, and cyclobenzaprine reduces muscle spasm by acting on the brainstem. The problem is that when you stack two central nervous system (CNS) depressants, you don’t just get double the relief. You also get amplified drowsiness, dizziness, impaired coordination, and slower reaction times. In more serious cases, the combination can suppress your breathing.

Opioids on their own can already cause respiratory depression by dampening the brainstem’s drive to breathe. When other CNS depressants are added, that suppression can deepen.² Most of the research on this danger has focused on opioid-plus-benzodiazepine combinations, which receive the most attention in FDA warnings. But muscle relaxants like cyclobenzaprine share enough of the same sedating properties that prescribing guidelines now flag the opioid-plus-muscle-relaxant combination as well.¹

That said, the risk isn’t identical across every scenario. A person taking a low dose of each for a few days after a back injury, under close supervision and with no other sedating substances, faces a different situation than someone on high doses of both for weeks, especially if alcohol or a benzodiazepine is also in the mix. The danger scales with dose, duration, and what else you’re taking.

The Serotonin Syndrome Angle

Beyond sedation and breathing problems, this particular combination has another, more surprising risk. Both hydrocodone and cyclobenzaprine can raise serotonin levels in the brain. Hydrocodone does so weakly, but cyclobenzaprine is structurally very similar to tricyclic antidepressants, which are well-known serotonin boosters. When the two drugs are combined, there’s a chance of pushing serotonin levels high enough to trigger serotonin syndrome, a condition marked by agitation, rapid heart rate, high body temperature, muscle twitching, and sometimes confusion or seizures.

A published case report describes exactly this scenario: a patient with cerebral palsy developed moderate serotonin syndrome after receiving additional doses of hydrocodone and cyclobenzaprine together.³ Serotonin syndrome is uncommon with this pair alone, but the risk climbs if you’re also on an antidepressant (especially an SSRI or SNRI), a migraine triptan, or any other medication that affects serotonin. If you’re prescribed both hydrocodone and cyclobenzaprine and you notice sudden agitation, fever, muscle rigidity, or uncontrollable twitching, seek medical attention quickly. These symptoms can escalate fast.

A Shared Metabolic Pathway in the Liver

Part of the reason this combination deserves attention is that hydrocodone and cyclobenzaprine are broken down by some of the same liver enzymes. Cyclobenzaprine is primarily metabolized by the enzymes CYP3A4 and CYP1A2.⁴ Hydrocodone also depends on CYP3A4 (along with CYP2D6) for its breakdown.⁵

When two drugs compete for the same enzyme, each one can slow the processing of the other. In practical terms, that can mean both drugs linger in your body longer at higher concentrations than they would individually. The result is a bigger sedative punch and a longer window during which side effects can occur. People who already metabolize drugs slowly through CYP3A4, whether due to genetics, liver disease, or other medications that inhibit that enzyme (certain antifungals, some antibiotics, grapefruit juice in large quantities), may see even more pronounced effects.

How Cyclobenzaprine Compares to Other Muscle Relaxants When Paired With Opioids

If cyclobenzaprine is risky with opioids, a natural question is whether switching to a different muscle relaxant would be safer. The evidence here is mixed but moderately reassuring about cyclobenzaprine’s relative standing. A large study using cyclobenzaprine as the reference point compared the overdose risk of various muscle relaxants used alongside prescription opioids. Baclofen stood out as substantially riskier, with roughly two and a half times the opioid-overdose hazard compared to cyclobenzaprine. Other muscle relaxants including methocarbamol, tizanidine, and carisoprodol showed no statistically significant difference from cyclobenzaprine.⁶

A separate study looked specifically at injury risk (not just overdose) in people using muscle relaxants and opioids concurrently. Among hundreds of thousands of patients who used a muscle relaxant alongside hydrocodone, the injury hazard ratios for various relaxants were generally not statistically significant.⁷ When the opioid was tramadol instead, cyclobenzaprine did show a modestly higher injury risk. So the pairing matters: the specific opioid in the combination influences the degree of danger, not just the muscle relaxant.

The takeaway isn’t that cyclobenzaprine is “safe” with opioids. It’s that among the commonly prescribed muscle relaxants, cyclobenzaprine doesn’t appear to be the worst choice when an opioid is also on board. Baclofen seems to carry more overdose risk in that context, and the others fall in a roughly similar range to cyclobenzaprine. None of them are risk-free.

The “Triple Threat” Problem

One scenario that doctors worry about far more than the two-drug combination is when a benzodiazepine (like alprazolam, diazepam, or lorazepam) gets added to an opioid and a muscle relaxant. Researchers have informally labeled this the “triple threat,” and the data backs up the alarm. A nationwide study found that patients using all three drug classes together had dramatically higher odds of ending up in the emergency department compared to people not on any of the three. The odds ratios were strikingly large, ranging from about six to nearly ten times higher depending on the year studied.⁸

If you’re currently prescribed all three classes, or if a new prescription would push you into that territory, it’s worth having a direct conversation with your doctor. The combined sedation load can impair your ability to drive, raise your fall risk considerably, and in the worst case lead to respiratory failure. Even if each individual medication is prescribed at a low dose, the additive (and sometimes multiplicative) effect on the CNS can surprise people who feel fine for the first few days and then experience a sudden episode of extreme drowsiness or confusion.

Older Adults Face Steeper Risks

Age changes the equation. Cyclobenzaprine is on lists of medications generally avoided in older adults because of its strong sedating properties and anticholinergic effects (dry mouth, constipation, urinary retention, confusion).⁹ Add an opioid to that, and you get a potent recipe for falls, which in an older person can mean hip fractures, head injuries, and a cascade of complications. The liver also processes drugs more slowly with age, meaning both hydrocodone and cyclobenzaprine can build up to higher-than-expected levels.

For people over 65, prescribers often look for alternatives to cyclobenzaprine altogether. Physical therapy, topical pain relievers, or non-sedating approaches to muscle spasm tend to be preferred. If both drugs are genuinely needed, the typical clinical approach involves using the lowest effective doses for the shortest possible time and monitoring closely for drowsiness or unsteadiness.

Pregnancy and Cyclobenzaprine

Most discussions of this drug combination focus on sedation and overdose, but pregnancy introduces a distinct concern. A large study analyzing data from two major U.S. birth defect surveillance programs found that women who used cyclobenzaprine around the time of conception had elevated odds of several serious birth defects in their babies. The strongest associations were with certain heart defects and cleft palate, with some odds ratios in the range of four to seven times higher than in unexposed pregnancies.¹⁰

The number of exposed cases in that study was small, so the confidence intervals were wide and these findings need further confirmation. But the signal was consistent across multiple defect types, which makes it harder to dismiss. The practical implication: if you’re pregnant or planning to become pregnant, cyclobenzaprine is generally something to avoid. Hydrocodone carries its own pregnancy risks (including neonatal withdrawal syndrome), so the combination is especially unappealing during this period. Talk to your prescriber about safer options for managing pain and muscle spasm.

What to Watch for If You’re Prescribed Both

Some doctors do prescribe hydrocodone and cyclobenzaprine together, particularly for acute musculoskeletal injuries where both pain and muscle spasm are severe. When they do, the strategy typically involves short-term use at the lowest effective doses, with clear instructions about what to avoid and what to report. If you find yourself in that situation, a few practical points are worth knowing.

Alcohol is off the table. Even a single drink adds another CNS depressant to the mix and can tip the balance toward dangerous sedation or breathing problems. Driving and operating machinery should also be avoided until you know exactly how the combination affects you; most people experience at least some impairment in reaction time and coordination. If you take any antidepressant, migraine medication, or anti-nausea drug that affects serotonin, mention it to your prescriber before starting this combination, since those drugs raise the serotonin syndrome risk discussed earlier.

Symptoms that warrant immediate medical attention include extreme drowsiness that you can’t fight through, slow or shallow breathing, confusion, a racing heartbeat combined with agitation or muscle rigidity, and any loss of consciousness. It’s also smart to have someone around who knows what you’re taking for the first day or two, so they can call for help if you become unresponsive. This isn’t fear-mongering; it’s the same practical precaution that applies any time two sedating drugs are combined.

Alternatives Worth Discussing With Your Doctor

When the goal is treating pain plus muscle tightness without stacking CNS depressants, several approaches exist. Non-opioid pain relief (anti-inflammatory drugs, acetaminophen, or topical agents like lidocaine patches) can sometimes replace hydrocodone, especially for musculoskeletal pain that isn’t surgical. On the muscle relaxant side, non-sedating options or physical therapy modalities like heat, stretching, and targeted exercise can address spasm without adding another depressant drug. Some prescribers use a staggered timing approach, having the patient take one drug during the day and the other only at bedtime, to reduce the peak overlap of sedation. This doesn’t eliminate the risk, but it can soften it.

If you’ve been on both medications for more than a couple of weeks, stopping either one suddenly can cause its own problems. Opioid withdrawal is well known, but abruptly discontinuing cyclobenzaprine after extended use can also trigger rebound muscle spasm and discomfort. Any changes to your regimen should be discussed with the prescribing clinician rather than made on your own.

Why This Combination Gets Prescribed Despite the Warnings

Given all these risks, you might wonder why any doctor would write prescriptions for both. The reality is that acute back injuries, post-surgical pain with muscle guarding, and similar conditions sometimes produce a level of suffering that non-sedating treatments can’t adequately control. In those scenarios, a short course of both drugs can provide relief that lets a person sleep, move, and participate in physical therapy sooner than they otherwise would. The medical calculation is that a few days of carefully monitored combined use may prevent a longer, more complicated recovery. Guidelines don’t outright prohibit the combination; they caution against it and recommend close monitoring when it’s used.¹

The study that used cyclobenzaprine as the reference muscle relaxant for opioid overdose risk found that no subgroup comparisons indicated cyclobenzaprine itself was associated with a higher overdose risk than the alternatives, and findings held even after excluding patients with a history of substance abuse.⁶ That doesn’t make the pairing harmless, but it does suggest that when a muscle relaxant must be used alongside an opioid, cyclobenzaprine is a reasonable choice compared to the alternatives. The key variable isn’t really which muscle relaxant you pick; it’s whether you need one at all, for how long, and what other drugs and risk factors are in the picture.